Literature DB >> 6381463

The use of rifampicin in staphylococcal infections--a review.

J E Kapusnik, F Parenti, M A Sande.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6381463     DOI： 10.1093/jac/13.suppl_c.61

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Cross-resistance of Escherichia coli RNA polymerases conferring rifampin resistance to different antibiotics.

Authors:  Ming Xu; Yan Ning Zhou; Beth P Goldstein; Ding Jun Jin
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

2.  Emergence and spread of rifampicin-resistant, methicillin-resistant Staphylococcus aureus during vancomycin-rifampicin combination therapy in an intensive care unit.

Authors:  O Ju; M Woolley; D Gordon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-01       Impact factor: 3.267

3.  Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.

Authors:  J C Lucet; M Herrmann; P Rohner; R Auckenthaler; F A Waldvogel; D P Lew
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

4.  Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia.

Authors:  T Q Tan; E O Mason; C N Ou; S L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.